Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication

MLA

Chunsheng Dong, et al. “Targeting Hepatitis B Virus CccDNA by CRISPR/Cas9 Nuclease Efficiently Inhibits Viral Replication.” Antiviral Research, vol. 118, Oct. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38f50f7b7489f6447e88abff754d38b5&authtype=sso&custid=ns315887.

APA

Chunsheng Dong, Lin Wei, Liang Qu, Sidong Xiong, Yuansu Dong, & Haoyi Wang. (2014). Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Antiviral Research, 118.

Chicago

Chunsheng Dong, Lin Wei, Liang Qu, Sidong Xiong, Yuansu Dong, and Haoyi Wang. 2014. “Targeting Hepatitis B Virus CccDNA by CRISPR/Cas9 Nuclease Efficiently Inhibits Viral Replication.” Antiviral Research 118 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38f50f7b7489f6447e88abff754d38b5&authtype=sso&custid=ns315887.